-
公开(公告)号：EP2408468B1
公开(公告)日：2014-04-30
申请号：EP10714095.6
申请日：2010-03-18
申请人： Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. , Hadasit Medical Research Services And Development Ltd. , Ben-Gurion University Of The Negev Research And Development Authority
IPC分类号： A61K38/17 , C07K14/705 , C07K16/28 , A61P3/10
CPC分类号： A61K39/3955 , A61K38/00 , A61K2039/505 , C07K14/705 , C07K14/70503 , C07K16/2803 , C07K16/2851 , C07K2319/30
-
公开(公告)号：EP2408468A2
公开(公告)日：2012-01-25
申请号：EP10714095.6
申请日：2010-03-18
申请人： Yissum Research Development Company of the Hebrew University of Jerusalem , Hadasit Medical Research Services And Development Ltd. , Ben-Gurion University Of The Negev Research And Development Authority
IPC分类号： A61K38/17
CPC分类号： A61K39/3955 , A61K38/00 , A61K2039/505 , C07K14/705 , C07K14/70503 , C07K16/2803 , C07K16/2851 , C07K2319/30
摘要： The invention relates to use of the natural cytotoxicity receptor NKp46 for preventing and treating diabetes, including type I diabetes (TID) and type 2 diabetes. In particular, the invention provides compositions comprising a fragment of the extracellular region of NKp46 for preventing the onset and progression of diabetes.
-
公开(公告)号：EP3218003B1
公开(公告)日：2020-10-21
申请号：EP15816249.5
申请日：2015-11-10
-
4.发明公开ATTENUATED OR INACTIVATED PATHOGENIC ESCHERICHIA COLI FOR TREATING UROGENITAL CANCER 审中-公开减毒或灭活致病性大肠埃希氏菌大肠癌治疗尿路肉瘤
公开(公告)号：EP3218003A2
公开(公告)日：2017-09-20
申请号：EP15816249.5
申请日：2015-11-10
申请人： Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. , HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
摘要： The present invention provides attenuated or inactivated pathogenic bacteria having anti-cancer properties, compositions comprising the bacteria, and use thereof for treating cancers of the urogenital system.
摘要翻译： 本发明提供了具有抗癌特性的减毒或灭活病原菌，包含该细菌的组合物，以及其用于治疗泌尿生殖系统癌症的用途。
-
-
-
搜索结果
4 条记录 (耗时 0.026 秒)
